DISCUSSION: Leukemics often are immunosuppressed for days to weeks secondary to induction chemotherapy or stem cell transplantation. Literature shows leukemics with Sm infections are uniquely at risk for pulmonary hemorrhage and high mortality. A recent 2013 review of 1,085 HSCT patients showed 42 seperate Sm infections, seven of which developed pulmonary hemorrhage and died. Pulmonary hemorrhage was not seen among non-HSCT patients. Upon further review, prolonged neutropenia, high CRP and D-index were associated with hemorrhage. Previous papers found neutropenia and thrombocytopenia risk factors for hemorrhage after chemotherapy, with mortality occuring in 36-72 hours. Although unknown, alveolar damage was found in histological specimens. Blood and sputum culture did not result until the patient expired.